|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| VAT taxes receivable | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use asset | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Due to related party | ||||||||||||||||||||
| Accrued liabilities - related party | ||||||||||||||||||||
| Note payable - related party | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Line of credit | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Promissory notes | ||||||||||||||||||||
| Promissory note, net | ||||||||||||||||||||
| Non-redeemable convertible note, net - related party | ||||||||||||||||||||
| Convertible promissory notes, net | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Operating lease right-of-use liability | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Line of credit | ||||||||||||||||||||
| Promissory notes | ||||||||||||||||||||
| Non-redeemable convertible notes, net | ||||||||||||||||||||
| Operating lease right-of-use liability, net of current portion | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Temporary equity value | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Series C Preferred Stock | ||||||||||||||||||||
| Series D Preferred Stock | ||||||||||||||||||||
| Series E Preferred Stock | ||||||||||||||||||||
| Total temporary equity | ||||||||||||||||||||
| Preferred stock; $0.001 par value; 1,000,000 shares authorized, 0 issued and outstanding | ||||||||||||||||||||
| Total preferred stock; $0.001 par value; 1,000,000 shares authorized, 0 issued and outstanding | ||||||||||||||||||||
| Common stock; $0.0001 par value; 12,000,000,000 shares authorized, 7,536,382,467 and 6,501,509,691 shares issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||||
| Total liabilities and stockholders' deficit | ||||||||||||||||||||
Loading...
